SAFE vs Convertible Note in Pakistan: Which Instrument, When

Founders usually meet these two instruments as templates: the investor sends one, and the question becomes whether to sign it, not whether it is the right document. That is the wrong order. As of July 2026, the choice between a SAFE and a convertible note into a Pakistani private company is a genuine legal decision, because the two instruments sit in different places under Pakistani law and fail in different ways. This briefing sets out the decision, not the instruments themselves — for the underlying mechanics, see our references on SAFEs in Pakistan and convertible notes.

Two promises with different legal characters

Strip away the templates and the difference is simple. A SAFE is money now against a promise of shares on a trigger — no interest, no repayment date. Under Pakistani law it is a creature of the Contract Act, 1872 and nothing more: until an allotment actually happens under the Companies Act, 2017, the investor holds a contractual claim, not shares. A convertible note is a loan first. It carries interest, it matures, and conversion is an option layered on top of a debt. That single distinction — contract claim versus debt — drives almost every downstream consequence: what the company owes if no round arrives, how a foreign investor's money is classified at the border, what gets taxed, and what a court would order if the relationship breaks.

Neither instrument is named in any Pakistani statute. Both therefore live or die on drafting, and both must eventually pass through the same gate: an issue of shares by a private company, with the pre-emption offer to existing members under section 83 of the Companies Act, 2017, the shareholder authority needed to place shares with an outsider instead, sufficient authorised capital, a board allotment, and a return of allotment filed with the SECP. The instruments differ in everything that happens before that gate.

The comparison, side by side

Feature	SAFE	Convertible note
Conversion trigger	Priced equity round, sale, or dissolution — no date	Priced round, sale, or maturity date
Interest	None	Accrues, and compounds the conversion entitlement
Maturity	None — can hang indefinitely unless a longstop is drafted in	Fixed date; repayment or forced conversion falls due
Legal character in Pakistan	Contract Act, 1872 claim; holder is not a member until allotment under the Companies Act, 2017	Debt; a borrowing on the company's balance sheet from day one
If the investor is foreign	Remittance arrives with no shares issued against it — a timing gap under the Foreign Exchange Regulation Act, 1947 and the State Bank's Foreign Exchange Manual [TREATMENT OF SAFE-STYLE ADVANCES — TO BE VERIFIED BY REVIEWING LAWYER]	A foreign-currency borrowing by a resident company — a regulated activity under the 1947 Act requiring the State Bank framework for private foreign loans to be satisfied before the money moves [CURRENT REGISTRATION ROUTE — TO BE VERIFIED BY REVIEWING LAWYER]
Tax friction	None recurring before conversion	Interest paid or credited to a non-resident attracts withholding under the Income Tax Ordinance, 2001 [RATE AND TREATY RELIEF — TO BE VERIFIED BY REVIEWING LAWYER]
Downside if no round happens	Investor waits, or exits only on sale or winding up — unsecured	Debt matures; the company owes real money at the worst possible time
Stamping	Stampable as an agreement under the provincial Stamp Act, 1899	May attract higher duty as a bond or debt instrument [CLASSIFICATION AND RATES BY PROVINCE — TO BE VERIFIED BY REVIEWING LAWYER]

When the note is the better answer

Choose a note when the investor is local and wants downside protection that means something. A Pakistani angel or fund lending in rupees faces none of the exchange-control machinery; the note is simply a loan under the Contract Act, 1872, and if the promised round never materialises the investor holds a debt claim enforceable in the ordinary way, with interest compensating for the wait. Notes also suit bridges: a company six months from a priced Series A, borrowing from its own existing investors, is exactly the situation the instrument was built for, because the maturity date is short and the conversion event is already in motion. And a note disciplines both sides. A founder who knows the money becomes repayable in eighteen months prices and plans differently from one holding perpetual SAFE money.

The note's weaknesses are the mirror of its strengths. Maturity is a cliff: if the round slips, the company must repay, extend, or convert under pressure, and extension negotiations conducted by a cash-poor company rarely improve its terms. Interest quietly grows the conversion stack, which founders forget to model. And with a foreign lender the note is the harder instrument at the border, not the easier one — a private foreign-currency loan sits inside a State Bank approval and reporting regime under the Foreign Exchange Regulation Act, 1947 that many early-stage deals discover only after signing [SCOPE OF CURRENT PRIVATE FOREIGN BORROWING FRAMEWORK — TO BE VERIFIED BY REVIEWING LAWYER].

When the SAFE is the better answer

Choose a SAFE when the money is genuinely patient and the relationship cannot support a creditor. Accelerator cheques, small first cheques from people who understand they may wait years, and rounds where the company cannot responsibly take on a repayment obligation all point toward the SAFE. Because nothing accrues and nothing matures, the instrument never forces a crisis on its own; the company's obligations sleep until a trigger arrives. For founders, that is the entire appeal.

The costs are equally specific. The investor holds only a contract, so if the company is wound up before conversion the claim ranks as unsecured — a point worth stating plainly to any investor who believes a SAFE is "basically shares." An unadapted US-form SAFE also assumes conversion machinery that does not exist here; the approvals, the pre-emption position under section 83 of the Companies Act, 2017, and the authorised-capital headroom must all be built into the document at signing. And for foreign investors the SAFE presents the deepest structural issue of all: money remitted today against shares issued at an unknown future date sits awkwardly with a reporting framework built around shares issued against the remittance, which is a conversation to have with the authorised dealer before the wire, not after [CURRENT FE MANUAL POSITION — TO BE VERIFIED BY REVIEWING LAWYER].

The offer itself has a boundary

Whichever instrument wins, remember that offering it is itself a regulated act if done widely. A raise conducted by circulating an instrument that will convert into shares must stay inside the private placement boundary drawn by the Securities Act, 2015 and the Private Placement of Securities Rules, 2017; an offer made to too broad a circle risks recharacterisation as a public offer [NUMERICAL LIMITS AND APPLICATION TO CONVERTIBLES — TO BE VERIFIED BY REVIEWING LAWYER]. Early-stage companies raising from many small cheques on identical instruments should take this seriously before, not after, the round closes. Structuring the round to stay inside that boundary is core work for any adviser on a raise — see our fundraising and investment practice.

A decision sequence, not a preference

In practice the choice reduces to four questions asked in order. First, who is the investor — because a foreign investor changes the analysis entirely under the Foreign Exchange Regulation Act, 1947, and often changes the answer to "raise at a foreign holding company instead." Second, how real is the priced round — a bridge to a signed term sheet tolerates a note's maturity; an open-ended seed raise does not. Third, can the company survive the instrument failing — a note that matures into an empty bank account is a company-ending event; a SAFE that never converts is merely an unhappy investor. Fourth, what does the cap table need to look like afterwards — stacked instruments with different caps and discounts convert into a mess, and the time to model that is before the second cheque, not at the Series A.

What this means for you

Do not accept either template as neutral. If your investor is foreign, resolve the exchange-control route with the bank before any money moves, whichever instrument you choose — the Foreign Exchange Regulation Act, 1947 does not care which PDF you signed. If your investor is local and wants protection, give a note honestly rather than a SAFE dressed as one, and model the maturity date against your realistic runway. If you take a SAFE, adapt it: build the section 83 approvals, the authorised-capital covenant, and a longstop into the document at signing. And whichever instrument you use, count the offerees and stay inside the Securities Act, 2015 private placement boundary. The instrument that is right for your round is the one whose failure mode your company can survive.